A mouse model of Zhu-Tokita-Takenouchi-Kim syndrome reveals indispensable SON functions in organ development and hematopoiesis

Lana Vukadin, Bohye Park,Mostafa Mohamed,Huashi Li,Amr Elkholy, Alex Torrelli-Diljohn,Jung-Hyun Kim,Kyuho Jeong,James M. Murphy, Caitlin A. Harvey, Sophia Dunlap, Leah Gehrs, Hanna Lee,Hyung-Gyoon Kim, Jay Prakash Sah, Seth N. Lee, Denise Stanford,Robert A. Barrington, Jeremy B. Foote,Anna G. Sorace,Robert S. Welner, Blake E. Hildreth III, Ssang-Taek Steve Lim,Eun-Young Erin Ahn

JCI INSIGHT(2024)

引用 0|浏览0
暂无评分
摘要
Rare diseases are underrepresented in biomedical research, leading to insufficient awareness. ZhuTokita-Takenouchi-Kim (ZTTK) syndrome is a rare disease caused by genetic alterations that result in heterozygous loss of function of SON. While patients with ZTTK syndrome live with numerous symptoms, the lack of model organisms hampers our understanding of SON and this complex and identified the indispensable roles of Son in organ development and hematopoiesis. Son+/- mice recapitulated clinical symptoms of ZTTK syndrome, including growth retardation, cognitive impairment, skeletal abnormalities, and kidney agenesis. Furthermore, we identified hematopoietic observed in human patients. Surface marker analyses and single-cell transcriptome profiling of toward the myeloid lineage but compromised lymphoid lineage development by reducing genes the importance of the full gene expression of Son in multiple organs. Our model serves as an invaluable research tool for this rare disease and related disorders associated with SON dysfunction.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要